Skip to content
Medical Health Aged Care

Pearl Partners with Centaur to Expand Adoption of Second Opinion® in Australia and the Middle East

Pearl 3 mins read
LOS ANGELES--BUSINESS WIRE--

Pearl, the global leader in dental AI solutions, today announced a strategic partnership with Centaur, Australia’s leading dental practice management systems provider, and its Mediasuite platform, a leader in digital dental solutions across Australia, the Middle East and worldwide. This collaboration expands the reach of Pearl’s industry-leading Second Opinion® AI software, extending fully integrated access to groundbreaking disease detection capabilities for dental professionals across Australia and the Middle East.

Second Opinion® is the first-and-only chairside AI software with global regulatory clearances to assist dentists in the detection of numerous common conditions in bitewing, periapical, and panoramic X-rays. The software will be natively integrated within Centaur’s Mediasuite platform, enhancing diagnostic capabilities and improving patient communication workflows for dental professionals.

“Our partnership with Centaur represents a critical milestone in our global expansion,” said Ophir Tanz, founder and CEO of Pearl. “Centaur has long been a leader in the Australian dental market, and its strong presence in the Asia Pacific Region and Middle East positions this collaboration to significantly improve clinical efficiency and the standard of care for patients in these regions. By combining Pearl’s cutting-edge AI technology with Centaur’s established software infrastructure, we are making Second Opinion® more accessible to dental professionals, ensuring better patient outcomes and streamlined workflows.”

Centaur’s Mediasuite is widely recognized in the dental industry for its comprehensive set of digital tools, which provide seamless integration with a wide range of imaging hardware and software. The collaboration with Pearl will allow Centaur’s customers to leverage the full power of Second Opinion®’s AI-based diagnostic capabilities directly within the Mediasuite platform. This integration will provide automated evaluations of 2D intraoral X-rays, delivering faster, more accurate diagnoses and enhancing clinical decision-making in real time.

“We’re excited to expand our offerings in partnership with Pearl, whose innovative AI solutions align perfectly with Centaur’s mission to enhance dental care through advanced technology,” said Sean Perera, CTO of Centaur. “Second Opinion® represents the next generation of diagnostic tools for the dental profession. By incorporating AI-powered evaluations, we’re enabling dental professionals across the Asia Pacific and Middle East to improve diagnostic accuracy, streamline patient communication, and ultimately deliver a higher standard of care.”

To learn more about Second Opinion®’s Centaur Mediasuite integration, visit pages.hellopearl.com/centaur-mediasuite.

About Pearl

Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays. With regulatory clearance in 120 countries, Pearl’s AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry’s global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit hellopearl.com/demo.

About Centaur

Centaur is a leading provider of dental software solutions in Australia and the Middle East, delivering innovative, integrated digital tools that help dental practices operate more efficiently. With a comprehensive suite of solutions including Mediasuite, Centaur supports dental professionals in improving their clinical workflows, enhancing patient communication, and providing high-quality care. Centaur is committed to bringing the latest advancements in dental technology to dental practices, empowering them to meet the evolving needs of the industry. For more information, visit Centaur’s website.


Contact details:

Media Contact
Kate Gundry
[email protected]
617-797-5174

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.